Trial Profile
Efficacy of mipomersen sodium in high-risk statin-intolerant patients with hypercholesterolaemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2012
Price :
$35
*
At a glance
- Drugs Mipomersen (Primary)
- Indications Coronary artery disease; Hypercholesterolaemia
- Focus Therapeutic Use
- 16 Apr 2012 New trial record
- 29 Mar 2012 Results presented at the 16th International Symposium on Atherosclerosis.